 |
| SonoCava Business Plan |
 |
| Using the results from the initial market feasibility study, we developed a business plan for the SonoCava concept. This required that we define the business model, develop a strategy for entering the market, construct a five year month to month financial model based on sound assumptions, determine staffing and management team needs, create an operations plan and develop an overall product development and commercialization schedule, which included navigating the 510(k) process. |
 |
| Pulmonary embolism (P.E.) is a medical condition that accounts for approximately 10% of in-hospital deaths. With this condition, blood clots float from a large vein in the lower body through the vena cava to the heart and lungs. Due to the tendency to develop complications, many patients are unable to receive anticoagulation therapy and therefore mechanical filtration by the use of a vena cava filter is the accepted therapy. SonoCava has patented a technique and device that combines two existing surgical components – intravascular ultrasound (IVUS) catheters and vena cava filters – to allow bedside placement of vena cava filters in patients at risk for P.E. This concept capitalizes on the emergence of optionally retrievable filters – currently appropriating the market share of non-retrievable filters by 20% annually – and enables a new customer group (pulmonologists and critical care specialists) within the industry segment. Time and cost savings to physicians, hospitals and patients infuse this innovation with tremendous value. SonoCava takes advantage of an emerging trend in the vena cava filter market and also enables an opportunity for new customers to benefit from our innovation. SonoCava’s product and service offering allows hospital administrators to lower their costs, provides patients with more convenience while undergoing this procedure, and also allows a new group of physicians to implant filters and procure a new revenue stream for their practice. The SonoCava product and technique are based on patented intellectual property and our initial research indicates that the SonoCava solution is a welcome innovation and that it will be adopted at the expense of existing procedures and devices. SonoCava's distinct competitive advantage focuses on the ability to harness the emerging growth trends of the market, a superior product offering, and the empowerment of a new customer group that was previously under-served. |
 |
| The completion of this business plan provided the entrepreneurial team with a cohesive, thorough and powerful tool for attracting investors and forging strategic partnerships. The technology and processes associated with innovation are rapidly gaining acceptance in the health care industry, thus validating the commercialization potential for the SonoCava innovation. |
 |
 |
business plan development & review |opportunity screening & market feasibility analysis | SBIR / STTR grants | managing growth
opportunity screening | business plan development | business plan editing & review
link | SBIR / STTR grant writing
© 2004-2005 Avocado Group™, LLC 
